CoChat

A Paradigmatic Case of Postselective Serotonin Reuptake Inhibitors Sexual Dysfunction or Withdrawal After Discontinuation of Selective Serotonin Reuptake Inhibitors?

Patacchini, Arianna, Cosci, Fiammetta · 2020 · Journal of Clinical Psychopharmacology

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

encephalitis, the patient received metilprednisolone and immunoglobulin. One week after immunotherapy, she continued with severe signs of deliriumand excited catatonia, despite treatment with lorazepam (12 mg/d) and dexmedetomidine (0.2–0.8 μg kg−1 h−1, intravenous injection). Based on previous reports of success in patients with catatonia and delirium, memantine was started at 10 mg/d and increased to a daily dose of 20 mg. A longitudinal assessment was done with clinimetric tools before and after treatment with memantine (Fig. 1). After 2 days of receiving memantine, the patient showed a marked improvement in alertness, attention, catatonia, and agitation. Dexmedetomidine and physical restraintswere suspended. She started to eat and talk, and to recover daily activities such as taking a bath by herself, walking, and reading. Memory, language, and orientation disturbances were observed, as well as residual delusions (paranoid and nihilistic). Fluctuating catatonic signs decreased. The presence of nmethyl-d-aspartate receptor autoantibodies in cerebrospinal fluid was confirmed (processed at Labco Laboratories, Barcelona, Spain). Delirium, catatonia, and psychotic symptoms remitted, and the MoCA test was obtained (13/30). Memantine was maintained, and lorazepam was suspended gradually. One month after discharge, the MoCA test score improved (21/30), and she showed a global functional recovery. After 6months of follow-up, treatment with memantine and levetiracetam continued. Th…

Overview

Integrity signals

Registry

Crossref · 10.1097/jcp.0000000000001154

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 17 references

Research works printed but not linked: 2

  1. 2006, Post SSRI sexual dysfunction, Am Soc Advance Pharmacother Tablet, 7, 2
  2. 2018, The diagnostic clinical interview for drug withdrawal 1 (DID W1), Riv Psichiatr, 53, 95

Cited by

See all 11

Metadata

Authors
Patacchini, A., & Cosci, F.
Affiliations
Maastricht University (NL)
Venue
Journal of Clinical Psychopharmacology
Published
2019-12-11
Volume
40
Issue
1
Pages
93-95
ISSN
  • 0271-0749 (ISSN-L)
  • 1533-712X
OpenAlex
W2996335645
Cited by
10
References
17
Citations by year
2025: 3 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1
FWCI
0.60
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion)
  • Florence Research (University of Florence) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
selective serotonin reuptake inhibitors, sexual dysfunction, antidepressant discontinuation, drug withdrawal
MeSH terms
Adult, Major Depressive Disorder, Humans, Male, Sexual Dysfunction, Physiological, Selective Serotonin Reuptake Inhibitors, Sexual Dysfunctions, Psychological, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Paradigmatic Case of Postselective Serotonin Reuptake Inhibitors Sexual Dysfunction or Withdrawal After Discontinuation of Selective Serotonin Reuptake Inhibitors? https://app.cochat.ai/papers/10.1097/jcp.0000000000001154
The paper
Patacchini, A., & Cosci, F. (2020). A Paradigmatic Case of Postselective Serotonin Reuptake Inhibitors Sexual Dysfunction or Withdrawal After Discontinuation of Selective Serotonin Reuptake Inhibitors? Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000001154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.